Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oligos Etc. was a specialized biotechnology company focused on the custom synthesis of high-purity DNA and RNA oligonucleotides. Established in 1989, the firm became a key supplier for researchers and pharmaceutical companies developing antisense therapeutics, diagnostics, and gene-based medicines. The company was recognized for its ability to produce large-scale, highly modified sequences that met stringent purity requirements. Headquartered in Wilsonville, Oregon, Oligos Etc. maintained a strong presence in the life sciences supply chain until its acquisition. In 2006, the company was acquired by Integrated DNA Technologies (IDT), which absorbed its specialized synthesis technologies and customer base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oligos Etc..